Jinghua Weikang Capsule Containing Quadruple Therapy for IgAN With Helicobacter Pylori Infection

  • End date
    Dec 31, 2024
  • participants needed
  • sponsor
    Peking University First Hospital
Updated on 9 May 2022


This study is to evaluate the efficacy and safety of the Jinghua Weikang Capsule (a Chinese patent medicine for peptic ulcer and gastritis) containing quadruple therapy (Jinghua Weikang Caplsule plus triple therpy) for eradicating Helicobacter pylori in IgA nephropathy.

Condition Helicobacter Pylori Infection
Treatment Bismuth-Containing Quadruple Therapy, JWC containing quadruple therapy
Clinical Study IdentifierNCT05320133
SponsorPeking University First Hospital
Last Modified on9 May 2022


Yes No Not Sure

Inclusion Criteria

IgA nephropathy diagnosed by renal biopsy
Current Helicobacter pylori infection
Age 18-65

Exclusion Criteria

History of Helicobacter pylori treatment
Present taking hormones or immunosuppressants
Malignant tumor and high-grade intraepithelial neoplasia and severe dysplasia of gastric mucosa
Allergy history to medicines used in the study
History of gastric surgery
Uncontrolled chronic diseases such as diabetes, cardiovascular and cerebrovascular diseases, respiratory diseases, mental disorders and other researchers are considered to affect treatment and assessment
Combined with other primary or secondary nephropathy except for IgAN
Combined with acute renal injury
Female patients with pregnancy, lactation and planned pregnancy
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note